AXON - アクソバント・サイエンシズ (Axovant Sciences Ltd.) アクソバント・サイエンシズ

 AXONのチャート


 AXONの企業情報

symbol AXON
会社名 Axovant Sciences Ltd (アクソバント・サイエンシズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 アクソバント・サイエンシズ(Axovant Sciences Ltd.)は臨床段階のバイオ医薬品会社である。同社はアルツハイマー病およびレヴィー小体認知症を含む認知症の治療薬の獲得・開発・商業化を行う。同社は認知症および関連する神経学的障害の認知的、機能的および行動的側面に対処するための製品候補のパイプラインを開発する予定である。同社はアルツハイマー病およびレビー小体(DLB)による認知症を治療するために、選択的5-ヒドロキシトリプタミン6受容体アンタゴニストであるリード製品候補のインジパルジンを開発する。また、DLB患者における急速眼球運動障害(REM)行動障害およびレヴィー小体認知症の患者における視覚幻覚の治療用、選択的5-ヒドロキシトリプタミン2A受容体インバースアゴニストであるネロタンセリンを開発する。同社のパイプラインには、RVT-103とRVT-104が含まれる。   アクソバント・サイエンシズは、バミュ―ダの臨床段階バイオ医薬品会社。主に、アルツハイマ―型認知症治療薬「RVT-101」の開発と商業化に焦点を当てる。「RVT-101」は、セロトニン5-HT6受容体アンタゴニストで、認知障害の治療に向けた新薬として注目される。本社はバミュ―ダの首都ハミルトン。   
本社所在地 11-12 St. James's Square Suite 1 3rd Floor London SW1Y 4LB GBR
代表者氏名 Pavan Cheruvu パヴァン・チェルーヴ
代表者役職名 Chief Executive Officer Director 最高経営責任者(CEO)
電話番号 +44 1295-5950
設立年月日 41913
市場名 NYSE(ニューヨーク証券取引所)
ipoyear ―年
従業員数 69人
url www.axovant.com
nasdaq_url https://www.nasdaq.com/symbol/axon
adr_tso
EBITDA EBITDA(百万ドル) -193.47800
終値(lastsale) 2.04
時価総額(marketcap) 249044807.52
時価総額 時価総額(百万ドル) 268.57770
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 228.68170
当期純利益 当期純利益(百万ドル) -204.19500
決算概要 決算概要 BRIEF: For the three months ended 30 June 2018 Axovant Sciences Ltd revenues was not reported. Net loss decreased 25% to $51.9M. Lower net loss reflects Stock-based Compensation in SGA decrease of 64% to $3.3M (expense) General and administrative (includes $14 decrease of 31% to $8.4M (expense) Stock-based Compensation in R&D decrease of 60% to $2.5M (expense).

 AXONのテクニカル分析


 AXONのニュース

   Commercial and Private Security Sectors Can Now Benefit From The Axon Network  2021/03/12 17:20:00 PR Newswire
SCOTTSDALE, Ariz., March 12, 2021 /PRNewswire/ -- Axon, the global leader in connected public safety technologies, is bringing its suite of advanced technology solutions to commercial and private security markets. These industries are now able to benefit from the same transparency and…
   Axon announces partnership with California-based Skydio to create line of public safety drones  2021/03/11 16:22:24 ABC15 Arizona
Axon Enterprise Inc., the public safety technology company based in Scottsdale, announced a strategic partnership with drone maker Skydio to produce a new product integration in autonomous drones.
   Axon and Skydio Partner to Bring US-Manufactured, AI-Powered Autonomous Drones to Public Safety  2021/03/11 12:30:00 PR Newswire
SEATTLE, March 11, 2021 /PRNewswire/ -- Axon (Nasdaq: AXON), the global leader in connected public safety technologies, and Skydio, the leading U.S. drone manufacturer and world leader in autonomous flight, today announced a strategic partnership to offer Skydio's world leading autonomous…
   Axon Releases 2021 Environmental, Social and Governance Report  2021/03/04 12:30:00 PR Newswire
SCOTTSDALE, Ariz., March 4, 2021 /PRNewswire/ -- Axon (Nasdaq: AXON), the global leader in connected public safety technologies, announced the release of its Environmental, Social and Governance (ESG) report and its first ever Corporate Social Responsibility Report (CSR) last week, in…
   Axon (AXON) Reports 2020 Revenue of $681 Million, Up 28%, Raises 2021 Outlook  2021/02/25 21:01:00 PR Newswire
SCOTTSDALE, Ariz., Feb. 25, 2021 /PRNewswire/ -- Dear Shareholders, Every day, we hear stories about how our products are improving policing and driving safer outcomes for everyone. SITUATION: OFFICER IN TROUBLE Agency: Midwestern agency with about 1,000 sworn officers Incident: An…
   Axon announces partnership with California-based Skydio to create line of public safety drones  2021/03/11 16:22:24 ABC15 Arizona
Axon Enterprise Inc., the public safety technology company based in Scottsdale, announced a strategic partnership with drone maker Skydio to produce a new product integration in autonomous drones.
   Axon and Skydio Partner to Bring US-Manufactured, AI-Powered Autonomous Drones to Public Safety  2021/03/11 12:30:00 PR Newswire
SEATTLE, March 11, 2021 /PRNewswire/ -- Axon (Nasdaq: AXON), the global leader in connected public safety technologies, and Skydio, the leading U.S. drone manufacturer and world leader in autonomous flight, today announced a strategic partnership to offer Skydio's world leading autonomous…
   Axon Releases 2021 Environmental, Social and Governance Report  2021/03/04 12:30:00 PR Newswire
SCOTTSDALE, Ariz., March 4, 2021 /PRNewswire/ -- Axon (Nasdaq: AXON), the global leader in connected public safety technologies, announced the release of its Environmental, Social and Governance (ESG) report and its first ever Corporate Social Responsibility Report (CSR) last week, in…
   Axon (AXON) Reports 2020 Revenue of $681 Million, Up 28%, Raises 2021 Outlook  2021/02/25 21:01:00 PR Newswire
SCOTTSDALE, Ariz., Feb. 25, 2021 /PRNewswire/ -- Dear Shareholders, Every day, we hear stories about how our products are improving policing and driving safer outcomes for everyone. SITUATION: OFFICER IN TROUBLE Agency: Midwestern agency with about 1,000 sworn officers Incident: An…
   There Has Never Been a Better Time to Buy Axon Stock  2021/02/19 18:02:34 InvestorPlace
Axon stock is one of the best growth stocks in the market. And with police spending increasing under Biden, the time to buy is now.
   Axon Releases 2021 Environmental, Social and Governance Report  2021/03/04 12:30:00 PR Newswire
SCOTTSDALE, Ariz., March 4, 2021 /PRNewswire/ -- Axon (Nasdaq: AXON), the global leader in connected public safety technologies, announced the release of its Environmental, Social and Governance (ESG) report and its first ever Corporate Social Responsibility Report (CSR) last week, in…
   Axon (AXON) Reports 2020 Revenue of $681 Million, Up 28%, Raises 2021 Outlook  2021/02/25 21:01:00 PR Newswire
SCOTTSDALE, Ariz., Feb. 25, 2021 /PRNewswire/ -- Dear Shareholders, Every day, we hear stories about how our products are improving policing and driving safer outcomes for everyone. SITUATION: OFFICER IN TROUBLE Agency: Midwestern agency with about 1,000 sworn officers Incident: An…
   There Has Never Been a Better Time to Buy Axon Stock  2021/02/19 18:02:34 InvestorPlace
Axon stock is one of the best growth stocks in the market. And with police spending increasing under Biden, the time to buy is now.
   Here's Where To Look For A Short Squeeze In The Reopening Restaurant Space  2021/02/16 16:10:16 Benzinga
Dine-in restaurants reopened at 25% capacity in New York over the weekend, and analysts are expecting a sharp rebound in struggling restaurant stocks this year. Danielle Shay, director of options at Simpler Trading, said Friday that one restaurant stock to watch in the near-term is short squeeze candidate Jack in the Box Inc. (NYSE: JACK ). Watching Jack In The Box: The WallStreetBets-fueled GameStop Corp. (NYSE: GME ) short squeeze has traders looking for short squeeze opportunities elsewhere. Shay told CNBC that Jack in the Box could be the best potential short squeeze play in the restaurant group. Related Link: Exclusive: Axon CEO Talks Insane Short-Seller Attack, Says 'My Secretary Was A Mole' … Full story available on Benzinga.com
   Exclusive: Axon CEO Talks Insane Short-Seller Attack, Says 'My Secretary Was A Mole'  2021/02/12 20:51:12 Benzinga
Rick Smith, CEO of Axon Enterprise Inc (NASDAQ: AXON ), joined Benzinga’s " Raz Report" on Friday. He discussed the origins of Axon and told the story of some unbelievable lengths short sellers went to back in 2004 to try to destroy the company, including installing a mole inside the company. Axon’s Origins: Smith said he’s been passionate about safety and self-defense since he was a child. When he was 23, he tracked down and called the patent holder for the taser gun to convince him to revive the technology. “As I got to know him, I discovered that he actually wasn’t that interested in owning any stock in the company. He was kind of skeptical and pretty jaded about business. He just wanted a very clear patent royalty,” Smith said. Ultimately, Axon ended up buying out the patent holder’s patents and a 5% stake. Axon has gotten more attention in the past year due to the political protests surrounding police killings. Smith is optimistic that a solution is just around the corner. “We will develop a taser-like weapon by the end of this decade…that will outperform a 9 millimeter [firearm],” Smith said.

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 アクソバント・サイエンシズ AXON Axovant Sciences Ltd.)

 twitter  (公式ツイッターやCEOツイッターなど)